Remote Follow-Up for pituitary tumors: safe or risky?
NCT ID NCT06297473
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares the safety of routine telephone or video follow-ups versus in-person visits for patients with non-functioning pituitary tumors. Over two years, 812 participants will be randomly assigned to remote or in-person check-ups. The goal is to see if remote follow-up is as safe as in-person care in preventing serious complications like adrenal crisis or severe sodium imbalances.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Telephone or video follow-up (behavioral intervention)
- What this could lead to
- If successful, this could allow patients with non-functioning pituitary tumors to safely have routine follow-ups by phone or video instead of traveling to the clinic.
- What could go wrong
- This is a non-inferiority trial, so it may show that remote follow-up is not as safe as in-person visits. The results may not apply to all patients, especially those with complex needs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 812 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2024
- Expected to finish
-
Aug 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Non-functioning pituitary tumor * Diagnosed \> 6 months from enrollment, i.e. found on MRI. Exclusion Criteria: * Planned pituitary surgery * Planned radiotherapy * Poor Danish skills * Patient is considered by the treating physician unsuitable for follow-up by telephone or video
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-functional pituitary adenoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Zealand University Hospital
Køge, Region Sjælland, 4600, Denmark